4.8 Article

Obesity-associated hyperleptinemia alters the gliovascular interface of the hypothalamus to promote hypertension

期刊

CELL METABOLISM
卷 33, 期 6, 页码 1155-+

出版社

CELL PRESS
DOI: 10.1016/j.cmet.2021.04.007

关键词

-

资金

  1. Marie SklodowskaCurie grant [675610]
  2. European Research Council (AdG grant Hypoflam) [695054]
  3. German Research Foundation under Germany's Excellence Strategy [390857198]
  4. Helmholtz Excellence Network
  5. US National Institutes of Health [HL084207]
  6. Department of Veterans Affairs [BX004249]
  7. University of Iowa Fraternal Order of Eagles Diabetes Research Center
  8. Iowa Neuroscience Institute
  9. Technische UniversitaEurot MuEuronchen - Institute for Advanced Study - German Excellence Initiative
  10. European Union Seventh Framework Programme [291763]
  11. European Research Council (STG grant AstroNeuroCrosstalk) [757393]
  12. German Research Foundation [SFB TRR152/P23, SFB TRR296]
  13. Marie Curie Actions (MSCA) [675610] Funding Source: Marie Curie Actions (MSCA)
  14. European Research Council (ERC) [757393] Funding Source: European Research Council (ERC)

向作者/读者索取更多资源

This study found that hyperleptinemia promotes obesity-induced hypertension through a HIF1a-VEGF signaling cascade in hypothalamic astrocytes. Blocking the HIF1a-VEGF pathway in astrocytes can protect from obesity-induced hypothalamic angiopathy, sympathetic hyperactivity, or arterial hypertension.
Pathologies of the micro-and macrovascular systems are a hallmark of the metabolic syndrome, which can lead to chronically elevated blood pressure. However, the underlying pathomechanisms involved still need to be clarified. Here, we report that an obesity-associated increase in serum leptin triggers the select expansion of the micro-angioarchitecture in pre-autonomic brain centers that regulate hemodynamic homeostasis. By using a series of cell-and region-specific loss-and gain-of-function models, we show that this pathophysiological process depends on hypothalamic astroglial hypoxia-inducible factor 1a-vascular endothelial growth factor (HIF1a-VEGF) signaling downstream of leptin signaling. Importantly, several distinct models of HIF1a-VEGF pathway disruption in astrocytes are protected not only from obesity-induced hypothalamic angiopathy but also from sympathetic hyperactivity or arterial hypertension. These results suggest that hyperleptinemia promotes obesity-induced hypertension via a HIF1a-VEGF signaling cascade in hypothalamic astrocytes while establishing a novel mechanistic link that connects hypothalamic micro-angioarchitecture with control over systemic blood pressure.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据